Portola Pharmaceuticals (PTLA) Short Interest Ratio & Short Volume → top AI stock (it’s not MSFT, GOOGL, AMZN or AAPL) (From Traders Agency) (Ad) Free PTLA Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share Short InterestStock Analysis Portola Pharmaceuticals Short Interest DataCurrent Short Volume12,950,000 sharesPrevious Short Volume13,680,000 sharesChange Vs. Previous Month-5.34%Dollar Volume Sold Short$232.32 millionShort Interest Ratio / Days to Cover3.1Last Record DateJune 15, 2020Outstanding Shares78,484,000 sharesPercentage of Shares Shorted16.50%Today's Trading Volume0 sharesAverage Trading Volume3,172,176 sharesToday's Volume Vs. Average0% Short Selling Portola Pharmaceuticals ? Sign up to receive the latest short interest report for Portola Pharmaceuticals and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatPTLA Short Interest Over TimePTLA Days to Cover Over TimePTLA Percentage of Float Shorted Over Time Ad Banyan Hill PublishingDon’t Miss Out on the AI Gold Rush That’s Just Getting Started“Titan of Tech” Bets Big on Tiny AI Company He’s made as much as 3,250,000% in just three years on companies like Facebook, Airbnb, and PayPal… But our research shows his latest investment could be his most successful venture yet.See how you can invest alongside him Portola Pharmaceuticals Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 6/15/202012,950,000 shares $232.32 million -5.3%N/A3.1 $17.94 5/29/202013,680,000 shares $245.56 million +22.9%N/A3.2 $17.95 5/15/202011,130,000 shares $198.34 million -38.6%N/A2.6 $17.82 4/30/202018,140,000 shares $128.25 million +0.5%N/A5.1 $7.07 4/15/202018,050,000 shares $124.36 million -1.3%N/A10.9 $6.89 3/31/202018,290,000 shares $130.41 million +0.3%N/A9.2 $7.13 3/13/202018,232,900 shares $137.48 million +3.5%N/A12 $7.54 2/28/202017,620,000 shares $178.14 million +0.5%N/A10.6 $10.11 2/14/202017,540,000 shares $239.42 million +1.5%N/A11.7 $13.65 1/31/202017,280,000 shares $221.01 million +11.5%N/A11.9 $12.79 1/15/202015,500,000 shares $230.95 million +2.0%N/A11.2 $14.90 12/31/201915,190,000 shares $362.74 million +9.1%N/A12.3 $23.88 PTLA Short Interest - Frequently Asked Questions What is Portola Pharmaceuticals' current short interest? Short interest is the volume of Portola Pharmaceuticals shares that have been sold short but have not yet been covered or closed out. As of June 15th, investors have sold 12,950,000 shares of PTLA short. Learn More on Portola Pharmaceuticals' current short interest. What is a good short interest ratio for Portola Pharmaceuticals? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. PTLA shares currently have a short interest ratio of 3.0. Learn More on Portola Pharmaceuticals's short interest ratio. Is Portola Pharmaceuticals' short interest increasing or decreasing? Portola Pharmaceuticals saw a decrease in short interest in the month of June. As of June 15th, there was short interest totaling 12,950,000 shares, a decrease of 5.3% from the previous total of 13,680,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Portola Pharmaceuticals' short interest compare to its competitors? Here is how the short interest of companies in the sector of "medical" compare to Portola Pharmaceuticals: Kura Oncology, Inc. (16.38%), Ligand Pharmaceuticals Incorporated (4.05%), Zai Lab Limited (3.90%), Morphic Holding, Inc. (11.79%), Arcus Biosciences, Inc. (17.43%), ANI Pharmaceuticals, Inc. (0.93%), Gyre Therapeutics, Inc. (0.87%), Dynavax Technologies Co. (13.73%), Protagonist Therapeutics, Inc. (5.90%), Edgewise Therapeutics, Inc. (9.11%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($4.67 billion), Match Group, Inc. ($3.64 billion), Wayfair Inc. ($3.47 billion), Tesla, Inc. ($3.00 billion), Ecolab Inc. ($2.97 billion), Morgan Stanley ($2.93 billion), The Charles Schwab Co. ($2.70 billion), Carnival Co. & plc ($2.38 billion), The Clorox Company ($2.29 billion), and Aon plc ($2.24 billion). View all of the most shorted stocks. What does it mean to sell short Portola Pharmaceuticals stock? Short selling PTLA is an investing strategy that aims to generate trading profit from Portola Pharmaceuticals as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Portola Pharmaceuticals? A short squeeze for Portola Pharmaceuticals occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of PTLA, which in turn drives the price of the stock up even further. How often is Portola Pharmaceuticals' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including PTLA, twice per month. The most recent reporting period available is June, 15 2020. More Short Interest Resources from MarketBeat Related Companies: Kura Oncology Short Interest Data Ligand Pharmaceuticals Short Interest Data Zai Lab Short Interest Data Morphic Short Interest Data Arcus Biosciences Short Interest Data ANI Pharmaceuticals Short Interest Data Gyre Therapeutics Short Interest Data Dynavax Technologies Short Interest Data Protagonist Therapeutics Short Interest Data Edgewise Therapeutics Short Interest Data Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:PTLA) was last updated on 4/23/2024 by MarketBeat.com Staff From Our PartnersSHOCKING Crypto Leak…Crypto 101 Mediatop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsDon’t Miss Out on the AI Gold Rush That’s Just Getting StartedBanyan Hill PublishingHow to camouflage a factory of 53,000 workersStansberry ResearchMan Who Predicted 2008: “This Will be Worse.”AltimetryExposed: 10 CENT Crypto to Explode April 20th?True Market InsidersExposed: How Big Banks Plan to Chain Your Wealth with Digital DollarsGoldenCrest Metals